Keywords: update, mgi, pharma, makes, 178m, bid, guilford
UPDATE: MGI Pharma makes $178M bid for Guilford, plus assuming $69.4M convertible debt
Article | 01 August 2005
Further consolidation of US mid-sized drug companies is forthcoming, with the proposed acquisition of Guilford Pharmaceuticals by MGI Pharma. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
